Andreas Voskrebenzev
Overview
Explore the profile of Andreas Voskrebenzev including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
486
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pohler G, Voskrebenzev A, Heinze M, Skeries V, Klimes F, Glandorf J, et al.
Radiology
. 2025 Feb;
314(2):e241596.
PMID: 39998374
Background Although measurable organic dysfunctions are frequently absent in pediatric patients with post-COVID-19 condition (PCC), this condition adversely affects quality of life. Free-breathing phase-resolved functional lung (PREFUL) MRI may be...
2.
Klimes F, Plummer J, Willmering M, Matheson A, Bdaiwi A, Gutberlet M, et al.
Magn Reson Med
. 2025 Jan;
93(5):1984-1998.
PMID: 39825520
Purpose: Pulmonary MRI faces challenges due to low proton density, rapid transverse magnetization decay, and cardiac and respiratory motion. The fermat-looped orthogonally encoded trajectories (FLORET) sequence addresses these issues with...
3.
Klimes F, Voskrebenzev A, Vogel-Claussen J
Radiol Cardiothorac Imaging
. 2024 Dec;
6(6):e240350.
PMID: 39665632
No abstract available.
4.
Behrendt L, Gutberlet M, Voskrebenzev A, Klimes F, Obert A, Kern A, et al.
NMR Biomed
. 2024 Oct;
37(12):e5270.
PMID: 39367655
Non-contrast enhanced H magnetic resonance imaging (MRI) is promising for ventilation/perfusion (V/Q) assessment of the lung but the influence of the echo time (TE) on V/Q parameters is lacking. Therefore,...
5.
Voskrebenzev A, Gutberlet M, Klimes F, Kaireit T, Shin H, Kauczor H, et al.
Front Med (Lausanne)
. 2024 Sep;
11:1418052.
PMID: 39296894
Introduction: Validation of functional free-breathing MRI involves a comparison to more established or more direct measurements. This procedure is cost-intensive, as it requires access to patient cohorts, lengthy protocols, expenses...
6.
Voskrebenzev A, Klimes F, Wacker F, Vogel-Claussen J
J Vis Exp
. 2024 Aug;
(210).
PMID: 39185874
Fourier decomposition is a contrast agent-free 1H MRI method for lung perfusion (Q) and ventilation (V) assessment. After image registration, the time series of each voxel is analyzed with regard...
7.
Klimes F, Kern A, Voskrebenzev A, Gutberlet M, Grimm R, Muller R, et al.
Eur Radiol
. 2024 Jul;
35(2):943-956.
PMID: 39060494
Objectives: 3D phase-resolved functional lung (PREFUL) MRI offers evaluation of pulmonary ventilation without inhalation of contrast agent. This study seeks to compare ventilation maps obtained from 3D PREFUL MRI with...
8.
Hahn J, Voskrebenzev A, Behrendt L, Klimes F, Pohler G, Wacker F, et al.
NMR Biomed
. 2024 Jul;
37(11):e5209.
PMID: 38994704
Phase-resolved functional lung (PREFUL) MRI is a proton-based, contrast agent-free technique derived from the Fourier decomposition approach to measure regional ventilation and perfusion dynamics during free-breathing. Besides the necessity of...
9.
Klimes F, Voskrebenzev A, Wacker F, Vogel-Claussen J
J Vis Exp
. 2024 Jul;
(208).
PMID: 38975766
Pulmonary magnetic resonance imaging (MRI) offers a variety of radiation-free techniques tailored to assess regional lung ventilation or its surrogates. These techniques encompass direct measurements, exemplified by hyperpolarized gas MRI...
10.
Stahl M, Dohna M, Graeber S, Sommerburg O, Renz D, Pallenberg S, et al.
Eur Respir J
. 2024 Jun;
64(3).
PMID: 38901883
Background: We recently demonstrated that elexacaftor/tezacaftor/ivacaftor (ETI) improves the lung clearance index (LCI) and abnormalities in lung morphology detected by magnetic resonance imaging (MRI) in adolescent and adult patients with...